Close Menu X
Kelley & Ferraro, LLP
Free Consultations ~ Practicing Nationwide
216-202-3450 800-398-1795

Pharmaceutical Liability Archives

Anti-malaria drug used by Army may cause brain damage

Army personnel from Ohio and other states have been ordered by the Surgeon General's Office of the Army Special Operations Command to stop using a drug that may induce permanent brain damage. The drug, known as mefloquine, was specifically designed by the Army during the 1970s as way to fight malaria, and its usage has spread to millions of travelers who were never in the military because of its low cost and ease of use.

Pfizer pays for improper marketing by Wyeth Pharmaceuticals

When drug giant Pfizer acquired Wyeth Pharmaceuticals in 2009, they also acquired a very large criminal and civil liability. According to the U.S. Department of Justice, Wyeth improperly marketed and mis-branded their drug Rapamune, approved in 2009 by the U.S. Food and Drug Administration for use by kidney transplant patients in Ohio and across the nation.

Buyers in Ohio and around U.S. endangered by online pharmacies

Ohio residents may be interested to learn that while the Food and Drug Administration (FDA) oversees all pharmaceutical drugs produced and distributed in the United States, it appears that the FDA and international organizations are finding law enforcement more difficult in cyberspace. As buyers seek out cheaper alternatives to purchasing medication in drug stores and pharmacies around the nation, online pharmacies are increasing their presence to take advantage of the available consumer base.

Groups urge White House to conclude safety review

Interest groups were putting pressure on the White House to compete its final safety review on medical device identifiers. Premier healthcare alliance, which represents purchasers of devices, and The Pew Charitable Trusts, a research organization, were asking the White House Office of Management and Budget, or OMB, to make a final decision concerning the Food and Drug Administration rule. The groups claim that the FDA missed a statutory deadline; they insist that the decision is necessary in order to provide safety and quality improvements regarding patient care in Ohio and all over the United States.

New Supreme Court ruling limits recovery avenues for patients

Ohio attorneys and patients are taking notice of a recent ruling by the Supreme Court stating that patients cannot sue generic drug makers for design defects, further limiting avenues of recovery for injured patients. Reversing an earlier state court's decision awarding $21 million to a victim injured by a generic medication, the ruling states that generic drug manufacturers are not liable for design defects because federal law requires them to replicate the brand name drug.

Awards & Recognition

Contact Us For A Free Case Evaluation

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Email Us For A Response